US 4,048,231 A · 4-[3-(Substituted amino)-2-hydroxypropoxy]-5,6,7,8-tetrahydro-1,6,7-naphthalenetriols

Abstract

Compounds having the formula ##STR1## wherein R.sub.1, R.sub.2 and R.sub.3 are hydrogen or acyl, and R.sub.4 is lower alkyl having utility in the treatment of coronary diseases.

Claims5

Dependent claims

A compound having the formula ##STR15## or a pharmaceutically acceptable salt thereof wherein R.sub.4 is lower alkyl having 1 to 4 carbon atoms.

Dependencies are inferred from the claim text.

Facts

Application

05/656,769Filed 9 Feb 1976

Granted

13 Sep 1977

Term ends

Not estimatedThe source records don’t support an estimate.

Classification7 codes

C07D 317/70
Ortho- or peri-condensed with carbocyclic rings or ring systems: condensed with ring systems containing two or more relevant rings
A61P 9/08
Drugs for disorders of the cardiovascular system: vasodilators for multiple indications
A61P 25/02
Drugs for disorders of the nervous system: for peripheral neuropathies
C07C 39/17
Polycyclic with no unsaturation outside the aromatic rings: containing other rings in addition to the six-membered aromatic rings , e.g.…

Abstract

Compounds having the formula ##STR1## wherein R.sub.1, R.sub.2 and R.sub.3 are hydrogen or acyl, and R.sub.4 is lower alkyl having utility in the treatment of coronary diseases.

4-[3-(Substituted amino)-2-hydroxypropoxy]-5,6,7,8-tetrahydro-1,6,7-naphthalenetriols

Life of this patent

Abstract

Claims5

4-[3-(Substituted amino)-2-hydroxypropoxy]-5,6,7,8-tetrahydro-1,6,7-naphthalenetriols

Life of this patent

Abstract

Claims5